Any failure of endpoints in addition to having to report these failures to the FDA, the company would have to advise investors of under sec regulations.
Ah, another investor who can't wrap their head around the fact that a futility rec does not mean failure.
(It just means it's likely to fail if allowed to proceed)
Market Data 
Markets 
AI
